Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Anne M. Skalicky, Anne M. Rentz, Zhimei Liu, Qayyim Said, Jo Anne Nakagawa, Michael D. Frost, James W. Wheless & David W. Dunn. (2018) Economic burden, work, and school productivity in individuals with tuberous sclerosis and their families. Journal of Medical Economics 21:10, pages 953-959.
Read now
Read now
Articles from other publishers (33)
Deborah A. Marshall, Brittany Gerber, Diane L. Lorenzetti, Karen V. MacDonald, Riley Jewel Bohach & Gillian R. Currie. (2023) Are We Capturing the Socioeconomic Burden of Rare Genetic Disease? A Scoping Review of Economic Evaluations and Cost-of-Illness Studies. PharmacoEconomics 41:12, pages 1563-1588.
Crossref
Crossref
Kathleen Morrisroe, Nora Sandorfi & Murray Barron. (2023) Health Care Utilization. Rheumatic Disease Clinics of North America 49:2, pages 359-375.
Crossref
Crossref
Grace Yang, Inna Cintina, Anne Pariser, Elisabeth Oehrlein, Jamie Sullivan & Annie Kennedy. (2022) The national economic burden of rare disease in the United States in 2019. Orphanet Journal of Rare Diseases 17:1.
Crossref
Crossref
Sree Deepika Padala, Chunhuan Lao, Kamal Solanki & Douglas White. (2022) Direct and indirect health‐related costs of systemic sclerosis in New Zealand. International Journal of Rheumatic Diseases 25:12, pages 1386-1394.
Crossref
Crossref
Jia Li, Lian Yang, Yitong Zhang, Hailun Liao, Yuan Ma & Qun Sun. (2022) Rare disease curative care expenditure-financing scheme-health provider–beneficiary group analysis: an empirical study in Sichuan Province, China. Orphanet Journal of Rare Diseases 17:1.
Crossref
Crossref
Hadiya Elahmar, Brian M. Feldman & Sindhu R. Johnson. (2022) Management of Calcinosis Cutis in Rheumatic Diseases. The Journal of Rheumatology 49:9, pages 980-989.
Crossref
Crossref
Leonardo Martin Calderon, Mitali Chaudhary & Janet E Pope. (2022) Healthcare utilization and economic burden in systemic sclerosis: a systematic review. Rheumatology 61:8, pages 3123-3131.
Crossref
Crossref
Julien Delaye, Pasquale Cacciatore & Anna Kole. (2022) Valuing the “Burden” and Impact of Rare Diseases: A Scoping Review. Frontiers in Pharmacology 13.
Crossref
Crossref
Malene Knarborg, Anders Løkke, Ole Hilberg, Rikke Ibsen & Melina Gade Sikjær. (2022) Direct and indirect costs of systemic sclerosis and associated interstitial lung disease: A nationwide population‐based cohort study. Respirology 27:5, pages 341-349.
Crossref
Crossref
Ling Xiang, Sandra M. Y. Kua & Andrea H. L. Low. (2022) Work Productivity and Economic Burden of Systemic Sclerosis in a Multiethnic Asian Population. Arthritis Care & Research 74:5, pages 818-827.
Crossref
Crossref
Yannick Allanore, Joel Constans, Dominique Godard, Gerard de Pouvourville, Stephane Bouee, Viviane Jeanbat, Clement Teissier, Katell Le Lay, Julien Chollet & Eric Hachulla. (2021) Quality of life in SSc-ILD patients: Understanding the impact of the ILD and the needs of the SSc-ILD patients and their need for caregivers in France. Journal of Scleroderma and Related Disorders 7:1, pages 49-56.
Crossref
Crossref
Yongcong Chen, Lin Wu, Jose J. Hernández‐Muñoz, Michael J. Miller, Melinda Pope, Yidan Huyan & Lixian Zhong. (2021) The economic burden of systemic sclerosis—A systematic review. International Journal of Rheumatic Diseases 25:2, pages 110-120.
Crossref
Crossref
Francesco Saverio MENNINI & Lara GITTO. (2022) APPROACHES TO ESTIMATING INDIRECT COSTS IN HEALTHCARE: MOTIVATIONS FOR CHOICE. JOURNAL OF EUROPEAN ECONOMY:Volume 21, Vol 21, No 1 (2022), pages 17-45.
Crossref
Crossref
Daniel Levin, Giada De Palma, Hannah Zou, Ava Hadi Zadeh Bazzaz, Elena Verdu, Barbara Baker, Maria Ines Pinto-Sanchez, Nader Khalidi, Maggie J Larché, Karen A. Beattie & Premysl Bercik. (2021) Fecal microbiome differs between patients with systemic sclerosis with and without small intestinal bacterial overgrowth. Journal of Scleroderma and Related Disorders 6:3, pages 290-298.
Crossref
Crossref
Jennifer J.Y. Lee, Monique A.M. Gignac & Sindhu R. Johnson. (2021) Employment outcomes in systemic sclerosis. Best Practice & Research Clinical Rheumatology 35:3, pages 101667.
Crossref
Crossref
Ting Zhou, Haijing Guan, Luying Wang, Yao Zhang, Mingjun Rui & Aixia Ma. (2021) Health-Related Quality of Life in Patients With Different Diseases Measured With the EQ-5D-5L: A Systematic Review. Frontiers in Public Health 9.
Crossref
Crossref
Alicia Aurora Rodríguez, Óscar Martínez, Imanol Amayra, Juan Francisco López-Paz, Mohammad Al-Rashaida, Esther Lázaro, Patricia Caballero, Manuel Pérez, Sarah Berrocoso, Maitane García, Paula María Luna, Paula Pérez-Núñez & Nicole Passi. (2021) Diseases Costs and Impact of the Caring Role on Informal Carers of Children with Neuromuscular Disease. International Journal of Environmental Research and Public Health 18:6, pages 2991.
Crossref
Crossref
Jesper Rømhild Davidsen, Jelle Miedema, Wim Wuyts, Maritta Kilpeläinen, Spyridon Papiris, Effrosyni Manali, Carlos Robalo Cordeiro, Antonio Morais, Montse Pérez, Guus Asijee, David Cendoya & Stéphane Soulard. (2020) Economic Burden and Management of Systemic Sclerosis-Associated Interstitial Lung Disease in 8 European Countries: The BUILDup Delphi Consensus Study. Advances in Therapy 38:1, pages 521-540.
Crossref
Crossref
Yanni FanShaun BenderWeizhi ShiDonald Zoz. (2020) Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States. Journal of Managed Care & Specialty Pharmacy 26:12, pages 1539-1547.
Crossref
Crossref
D. L. Klabukova, V. S. Krysanova, T. N. Ermolaeva, M. V. Davydovskaya & K. A. Kokushkin. (2020) Economic burden of systemic sclerosis: systematic review. FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology 13:3, pages 291-303.
Crossref
Crossref
Dinesh Khanna, Yannick Allanore, Christopher P Denton, Marco Matucci-Cerinic, Janet Pope, Barbara Hinzmann, Siobhan Davies, Janethe de Oliveira Pena & Oliver Distler. (2019) Patient perception of disease burden in diffuse cutaneous systemic sclerosis. Journal of Scleroderma and Related Disorders 5:1, pages 66-76.
Crossref
Crossref
Agnes Kocher, Michael Simon, Andrew A. Dwyer, Peter M. Villiger, Patrizia Künzler‐Heule, Sabina Geest, Lut Berben & Dunja Nicca. (2019) Developing a rare disease chronic care model: Management of systemic sclerosis (MANOSS) study protocol. Journal of Advanced Nursing 75:12, pages 3774-3791.
Crossref
Crossref
Zhou Zhou, Yanni Fan, Wenxi Tang, Xinyue Liu, Darren Thomason, Zheng-Yi Zhou, Dendy Macaulay & Aryeh Fischer. (2019) Economic Burden among Commercially Insured Patients with Systemic Sclerosis in the United States. The Journal of Rheumatology 46:8, pages 920-927.
Crossref
Crossref
Julia Spierings & Jacob M. van Laar. (2019) Is There a Place for Hematopoietic Stem Cell Transplantation in Rheumatology?. Rheumatic Disease Clinics of North America 45:3, pages 399-416.
Crossref
Crossref
Eve Wittenberg, Lyndon P. James & Lisa A. Prosser. (2019) Spillover Effects on Caregivers’ and Family Members’ Utility: A Systematic Review of the Literature. PharmacoEconomics 37:4, pages 475-499.
Crossref
Crossref
Natalie McCormick, Carlo A. Marra, Mohsen Sadatsafavi, Jacek A. Kopec & J. Antonio Aviña‐Zubieta. (2018) Excess Productivity Costs of Systemic Lupus Erythematosus, Systemic Sclerosis, and Sjögren's Syndrome: A General Population–Based Study. Arthritis Care & Research 71:1, pages 142-154.
Crossref
Crossref
David R. Pearson, Victoria P. Werth & Lisa Pappas-Taffer. (2018) Systemic sclerosis: Current concepts of skin and systemic manifestations. Clinics in Dermatology 36:4, pages 459-474.
Crossref
Crossref
Kathleen Morrisroe, Wendy Stevens, Joanne Sahhar, Gene-Siew Ngian, Candice Rabusa, Nava Ferdowsi, Catherine Hill, Susanna Proudman & Mandana Nikpour. (2017) Quantifying the direct public health care cost of systemic sclerosis. Medicine 96:48, pages e8503.
Crossref
Crossref
Aryeh Fischer, Evelina Zimovetz, Caroline Ling, Dirk Esser & Nils Schoof. (2017) Humanistic and cost burden of systemic sclerosis: A review of the literature. Autoimmunity Reviews 16:11, pages 1147-1154.
Crossref
Crossref
Natalie McCormick, Carlo A. Marra & J. Antonio Aviña-Zubieta. (2017) Productivity Losses and Costs in the Less-Common Systemic Autoimmune Rheumatic Diseases. Current Rheumatology Reports 19:11.
Crossref
Crossref
F.G. Pierri, B. Domingues, L.B. Zeni, J.P. Cunha, F.D. dos Santos, C.V. Baroncini, B. Vilaça, R.K. Ostapiuk, R. Vianna, C.S. Muller & S.C. Kowalski. (2017) ESCLEROSE SISTÊMICA ‐ IMPACTO ECONÔMICO. Revista Brasileira de Reumatologia 57, pages S93.
Crossref
Crossref
Renata Linertová, Lidia García-Pérez & Iñigo Gorostiza. 2017. Rare Diseases Epidemiology: Update and Overview. Rare Diseases Epidemiology: Update and Overview
283
297
.
May Y. Choi & Marvin J. Fritzler. (2016) Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis. Current Opinion in Rheumatology 28:6, pages 586-594.
Crossref
Crossref